Your browser doesn't support javascript.
loading
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine.
Dallérac, Glenn; Li, Xia; Lecouflet, Pierre; Morisot, Nadège; Sacchi, Silvia; Asselot, Rachel; Pham, Thu Ha; Potier, Brigitte; Watson, David J G; Schmidt, Staffan; Levasseur, Grégoire; Fossat, Pascal; Besedin, Andrey; Rivet, Jean-Michel; Coyle, Joseph T; Collo, Ginetta; Pollegioni, Loredano; Kehr, Jan; Galante, Micaela; Fone, Kevin C; Gardier, Alain M; Freret, Thomas; Contarino, Angelo; Millan, Mark J; Mothet, Jean-Pierre.
Affiliation
  • Dallérac G; Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, UMR 7286, CNRS, Aix-Marseille Université, 13344 Marseille, France; glenn.dallerac@universite-paris-saclay.fr jean-pierre.mothet@universite-paris-saclay.fr.
  • Li X; Université Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, 91190, Gif-sur-Yvette, France.
  • Lecouflet P; Université Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, 91190, Gif-sur-Yvette, France.
  • Morisot N; Université Paris-Saclay, CNRS, École Normale Supérieure Paris-Saclay, CentraleSupélec, Laboratoire LuMin, UMR 2036, 91190 Gif-sur-Yvette, France.
  • Sacchi S; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR 5287, Université de Bordeaux, CNRS, 33076 Bordeaux, France.
  • Asselot R; The Protein Factory 2.0, Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, 21100 Varese, Italy.
  • Pham TH; INSERM UMR-S-1075, Université de Caen Normandie, 14000 Caen, France.
  • Potier B; Laboratoire de Neuropharmacologie, Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Pharmacie, INSERM, Université Paris-Saclay, F-92296 Chatenay-Malabry, France.
  • Watson DJG; Université Paris-Saclay, CNRS, École Normale Supérieure Paris-Saclay, CentraleSupélec, Laboratoire LuMin, UMR 2036, 91190 Gif-sur-Yvette, France.
  • Schmidt S; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
  • Levasseur G; Pronexus Analytical AB, 167 33 Bromma, Sweden.
  • Fossat P; Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, UMR 7286, CNRS, Aix-Marseille Université, 13344 Marseille, France.
  • Besedin A; Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, CNRS, 33077 Bordeaux, France.
  • Rivet JM; INSERM UMR-S-1075, Université de Caen Normandie, 14000 Caen, France.
  • Coyle JT; Centre for Thérapeutique Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290 Croissy-sur-Seine, Paris, France.
  • Collo G; Department of Psychiatry, Harvard Medical School, Boston, MA 02115.
  • Pollegioni L; Laboratory for Psychiatric and Molecular Neuroscience, McLean Hospital, Belmont, MA 02478.
  • Kehr J; Division of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25125 Brescia, Italy.
  • Galante M; The Protein Factory 2.0, Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, 21100 Varese, Italy.
  • Fone KC; Pronexus Analytical AB, 167 33 Bromma, Sweden.
  • Gardier AM; Université Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, 91190, Gif-sur-Yvette, France.
  • Freret T; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
  • Contarino A; Laboratoire de Neuropharmacologie, Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Pharmacie, INSERM, Université Paris-Saclay, F-92296 Chatenay-Malabry, France.
  • Millan MJ; INSERM UMR-S-1075, Université de Caen Normandie, 14000 Caen, France.
  • Mothet JP; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR 5287, Université de Bordeaux, CNRS, 33076 Bordeaux, France.
Proc Natl Acad Sci U S A ; 118(23)2021 06 08.
Article de En | MEDLINE | ID: mdl-34083436
Prefrontal control of cognitive functions critically depends upon glutamatergic transmission and N-methyl D-aspartate (NMDA) receptors, the activity of which is regulated by dopamine. Yet whether the NMDA receptor coagonist d-serine is implicated in the dopamine-glutamate dialogue in the prefrontal cortex (PFC) and other brain areas remains unexplored. Here, using electrophysiological recordings, we show that d-serine is required for the fine-tuning of glutamatergic neurotransmission, neuronal excitability, and synaptic plasticity in the PFC through the actions of dopamine at D1 and D3 receptors. Using in vivo microdialysis, we show that D1 and D3 receptors exert a respective facilitatory and inhibitory influence on extracellular levels and activity of d-serine in the PFC, with actions expressed primarily via the cAMP/protein kinase A (PKA) signaling cascade. Further, using functional magnetic resonance imaging (fMRI) and behavioral assessment, we show that d-serine is required for the potentiation of cognition by D3R blockade as revealed in a test of novel object recognition memory. Collectively, these results unveil a key role for d-serine in the dopaminergic neuromodulation of glutamatergic transmission and PFC activity, findings with clear relevance to the pathogenesis and treatment of diverse brain disorders involving alterations in dopamine-glutamate cross-talk.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sérine / Dopamine / Cortex préfrontal / Récepteurs du N-méthyl-D-aspartate Limites: Animals Langue: En Journal: Proc Natl Acad Sci U S A Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sérine / Dopamine / Cortex préfrontal / Récepteurs du N-méthyl-D-aspartate Limites: Animals Langue: En Journal: Proc Natl Acad Sci U S A Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique